Back to Search Start Over

Reduction in IGF1 mRNA in the Human Subependymal Zone During Aging.

Authors :
Weissleder C
Barry G
Fung SJ
Wong MW
Double KL
Webster MJ
Weickert CS
Source :
Aging and disease [Aging Dis] 2019 Feb 01; Vol. 10 (1), pp. 197-204. Date of Electronic Publication: 2019 Feb 01 (Print Publication: 2019).
Publication Year :
2019

Abstract

The cell proliferation marker, Ki67 and the immature neuron marker, doublecortin are both expressed in the major human neurogenic niche, the subependymal zone (SEZ), but expression progressively decreases across the adult lifespan (PMID: 27932973). In contrast, transcript levels of several mitogens (transforming growth factor α, epidermal growth factor and fibroblast growth factor 2) do not decline with age in the human SEZ, suggesting that other growth factors may contribute to the reduced neurogenic potential. While insulin like growth factor 1 (IGF1) regulates neurogenesis throughout aging in the mouse brain, the extent to which IGF1 and IGF family members change with age and relate to adult neurogenesis markers in the human SEZ has not yet been determined. We used quantitative polymerase chain reaction to examine gene expression of seven IGF family members [IGF1, IGF1 receptor, insulin receptor and high-affinity IGF binding proteins (IGFBPs) 2, 3, 4 and 5] in the human SEZ across the adult lifespan (n=50, 21-103 years). We found that only IGF1 expression significantly decreased with increasing age. IGFBP2 and IGFBP4 expression positively correlated with Ki67 mRNA. IGF1 expression positively correlated with doublecortin mRNA, whereas IGFBP2 expression negatively correlated with doublecortin mRNA. Our results suggest IGF family members are local regulators of neurogenesis and indicate that the age-related reduction in IGF1 mRNA may limit new neuron production by restricting neuronal differentiation in the human SEZ.<br />Competing Interests: Disclosure Statement Cynthia Shannon Weickert is on an advisory board for Lundbeck, Australia Pty Ltd and in collaboration with Astellas Pharma Inc., Japan. All other authors have no conflicts of interest to disclose.

Details

Language :
English
ISSN :
2152-5250
Volume :
10
Issue :
1
Database :
MEDLINE
Journal :
Aging and disease
Publication Type :
Academic Journal
Accession number :
30705779
Full Text :
https://doi.org/10.14336/AD.2018.0317